Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

Peter Malfertheiner; Francis Megraud; Colm A O'Morain; John Atherton; Anthony T R Axon; Franco Bazzoli; Gian Franco Gensini; Javier P Gisbert; David Y Graham; Theodore Rokkas; Emad M El-Omar; Ernst J Kuipers; European Helicobacter Study Group (members, Leif Percival Andersen)

doi:10.1136/gutjnl-2012-302084

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

Peter Malfertheiner, Francis Megraud, Colm A O'Morain, John Atherton, Anthony T R Axon, Franco Bazzoli, Gian Franco Gensini, Javier P Gisbert, David Y Graham, Theodore Rokkas, Emad M El-Omar, Ernst J Kuipers, European Helicobacter Study Group (members, Leif Percival Andersen)

Afdeling for Klinisk Mikrobiologi

2085 Citationer (Scopus)

Abstract

Management of Helicobacter pylori infection is evolving and in this 4th edition of the Maastricht consensus report aspects related to the clinical role of H pylori were looked at again in 2010. In the 4th Maastricht/Florence Consensus Conference 44 experts from 24 countries took active part and examined key clinical aspects in three subdivided workshops: (1) Indications and contraindications for diagnosis and treatment, focusing on dyspepsia, non-steroidal anti-inflammatory drugs or aspirin use, gastro-oesophageal reflux disease and extraintestinal manifestations of the infection. (2) Diagnostic tests and treatment of infection. (3) Prevention of gastric cancer and other complications. The results of the individual workshops were submitted to a final consensus voting to all participants. Recommendations are provided on the basis of the best current evidence and plausibility to guide doctors involved in the management of this infection associated with various clinical conditions.

Originalsprog	Engelsk
Tidsskrift	Gut (English Edition)
Vol/bind	61
Udgave nummer	5
Sider (fra-til)	646-64
Antal sider	19
ISSN	0017-5749
DOI	https://doi.org/10.1136/gutjnl-2012-302084
Status	Udgivet - 2012

Adgang til dokumentet

10.1136/gutjnl-2012-302084

Citationsformater

Malfertheiner, P., Megraud, F., O'Morain, C. A., Atherton, J., Axon, A. T. R., Bazzoli, F., Gensini, G. F., Gisbert, J. P., Graham, D. Y., Rokkas, T., El-Omar, E. M., Kuipers, E. J., & European Helicobacter Study Group (members, Leif Percival Andersen) (2012). Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut (English Edition), 61(5), 646-64. https://doi.org/10.1136/gutjnl-2012-302084

Malfertheiner, P, Megraud, F, O'Morain, CA, Atherton, J, Axon, ATR, Bazzoli, F, Gensini, GF, Gisbert, JP, Graham, DY, Rokkas, T, El-Omar, EM, Kuipers, EJ & European Helicobacter Study Group (members, Leif Percival Andersen) 2012, 'Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report', Gut (English Edition), bind 61, nr. 5, s. 646-64. https://doi.org/10.1136/gutjnl-2012-302084

@article{2873ea358afe48019546a32b46c10618,

title = "Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report",

abstract = "Management of Helicobacter pylori infection is evolving and in this 4th edition of the Maastricht consensus report aspects related to the clinical role of H pylori were looked at again in 2010. In the 4th Maastricht/Florence Consensus Conference 44 experts from 24 countries took active part and examined key clinical aspects in three subdivided workshops: (1) Indications and contraindications for diagnosis and treatment, focusing on dyspepsia, non-steroidal anti-inflammatory drugs or aspirin use, gastro-oesophageal reflux disease and extraintestinal manifestations of the infection. (2) Diagnostic tests and treatment of infection. (3) Prevention of gastric cancer and other complications. The results of the individual workshops were submitted to a final consensus voting to all participants. Recommendations are provided on the basis of the best current evidence and plausibility to guide doctors involved in the management of this infection associated with various clinical conditions.",

keywords = "Anti-Bacterial Agents, Anti-Inflammatory Agents, Non-Steroidal, Clarithromycin, Drug Therapy, Combination, Gastroesophageal Reflux, Gastroscopy, Helicobacter Infections, Helicobacter pylori, Humans, Prebiotics, Probiotics, Proton Pump Inhibitors, Stomach Neoplasms",

author = "Peter Malfertheiner and Francis Megraud and O'Morain, {Colm A} and John Atherton and Axon, {Anthony T R} and Franco Bazzoli and Gensini, {Gian Franco} and Gisbert, {Javier P} and Graham, {David Y} and Theodore Rokkas and El-Omar, {Emad M} and Kuipers, {Ernst J} and {European Helicobacter Study Group (members, Leif Percival Andersen)} and Andersen, {Leif Percival}",

year = "2012",

doi = "10.1136/gutjnl-2012-302084",

language = "English",

volume = "61",

pages = "646--64",

journal = "Gut (English Edition)",

issn = "0017-5749",

publisher = "BMJ Publishing Group",

number = "5",

}

TY - JOUR

T1 - Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

AU - Malfertheiner, Peter

AU - Megraud, Francis

AU - O'Morain, Colm A

AU - Atherton, John

AU - Axon, Anthony T R

AU - Bazzoli, Franco

AU - Gensini, Gian Franco

AU - Gisbert, Javier P

AU - Graham, David Y

AU - Rokkas, Theodore

AU - El-Omar, Emad M

AU - Kuipers, Ernst J

AU - European Helicobacter Study Group (members, Leif Percival Andersen)

A2 - Andersen, Leif Percival

PY - 2012

Y1 - 2012

N2 - Management of Helicobacter pylori infection is evolving and in this 4th edition of the Maastricht consensus report aspects related to the clinical role of H pylori were looked at again in 2010. In the 4th Maastricht/Florence Consensus Conference 44 experts from 24 countries took active part and examined key clinical aspects in three subdivided workshops: (1) Indications and contraindications for diagnosis and treatment, focusing on dyspepsia, non-steroidal anti-inflammatory drugs or aspirin use, gastro-oesophageal reflux disease and extraintestinal manifestations of the infection. (2) Diagnostic tests and treatment of infection. (3) Prevention of gastric cancer and other complications. The results of the individual workshops were submitted to a final consensus voting to all participants. Recommendations are provided on the basis of the best current evidence and plausibility to guide doctors involved in the management of this infection associated with various clinical conditions.

AB - Management of Helicobacter pylori infection is evolving and in this 4th edition of the Maastricht consensus report aspects related to the clinical role of H pylori were looked at again in 2010. In the 4th Maastricht/Florence Consensus Conference 44 experts from 24 countries took active part and examined key clinical aspects in three subdivided workshops: (1) Indications and contraindications for diagnosis and treatment, focusing on dyspepsia, non-steroidal anti-inflammatory drugs or aspirin use, gastro-oesophageal reflux disease and extraintestinal manifestations of the infection. (2) Diagnostic tests and treatment of infection. (3) Prevention of gastric cancer and other complications. The results of the individual workshops were submitted to a final consensus voting to all participants. Recommendations are provided on the basis of the best current evidence and plausibility to guide doctors involved in the management of this infection associated with various clinical conditions.

KW - Anti-Bacterial Agents

KW - Anti-Inflammatory Agents, Non-Steroidal

KW - Clarithromycin

KW - Drug Therapy, Combination

KW - Gastroesophageal Reflux

KW - Gastroscopy

KW - Helicobacter Infections

KW - Helicobacter pylori

KW - Humans

KW - Prebiotics

KW - Probiotics

KW - Proton Pump Inhibitors

KW - Stomach Neoplasms

U2 - 10.1136/gutjnl-2012-302084

DO - 10.1136/gutjnl-2012-302084

M3 - Journal article

C2 - 22491499

SN - 0017-5749

VL - 61

SP - 646

EP - 664

JO - Gut (English Edition)

JF - Gut (English Edition)

IS - 5

ER -

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater